Advertisement

Picture EBD Group BioPharm America 2018 Boston September 600x60px

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2859 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
British Business Bank. (6/13/18). "Press Release: £2.5bn British Patient Capital Programme Launched to Enable Long-term Investment in Innovative Companies across the UK". 2018-06-13
Philips. (6/13/18). "Press Release: Philips Expands Its Therapeutic Care Business with the Acquisition of Remote Diagnostic Technologies". Amsterdam. 2018-06-13
AstraZeneca plc. (6/12/18). "Press Release: Update on Phase III Clinical Trials of Lanabecestat for Alzheimer’s Disease. Independent Data Monitoring Committee Advises Lanabecestat Is Unlikely to Meet Primary Endpoints, Leading to Decision to Discontinue 2018-06-12
Autolus Therapeutics Ltd.. (6/8/18). "Press Release: Autolus Launches Roadshow for Initial Public Offering". London. 2018-06-08
Autolus Therapeutics Ltd.. (6/8/18). "Press Release: Autolus Announces Appointment of Linda Bain to Its Board of Directors". London. 2018-06-08
Autolus Therapeutics Ltd.. (6/8/18). "Press Release: Autolus Announces Appointment of Andrew J. Oakley as Senior Vice President and Chief Financial Officer". London. 2018-06-08
European Commission. (6/7/18). "Press Release: EU Budget – Commission Proposes Most Ambitious Research and Innovation Programme Yet". Brussels. 2018-06-07
University of Oxford. (6/6/18). "Press Release: Rosalind Franklin Institute Will »Transform« Life Sciences Research through Disruptive Technologies". 2018-06-06
Microbiotica Ltd.. (6/6/18). "Press Release: Microbiotica Enters into Microbiome Collaboration with Genentech". Cambridge. 2018-06-06
Oxford BioMedica plc. (6/6/18). "Press Release: Oxford BioMedica and Axovant Sciences Enter into a $842.5 Million Exclusive Worldwide Licence Agreement for OXB-102 for the Treatment of Parkinson’s Disease". Oxford. 2018-06-06
Thermo Fisher Scientific Inc.. (6/4/18). "Press Release: New Software Toolset Advances Small Molecule Analysis". San Diego, CA. 2018-06-04
Thermo Fisher Scientific Inc.. (6/4/18). "Press Release: Thermo Fisher Scientific Recognizes Tandem Mass Tag Grant Award Winners at ASMS 2018". San Diego, CA. 2018-06-04
Thermo Fisher Scientific Inc.. (6/4/18). "Press Release: Mass Spectrometer System Offers Solution for Small Molecule Identification and Characterization". San Diego, CA. 2018-06-04
Thermo Fisher Scientific Inc.. (6/4/18). "Press Release: New Ultra-High Mass Range Mass Spectrometer Provides Solution for Analysis of Proteins and Protein Complexes". San Diego, CA. 2018-06-04
Thermo Fisher Scientific Inc.. (6/4/18). "Press Release: New Triple Quadrupole Mass Spectrometer Brings Speed and High Performance to Routine Laboratories". San Diego, CA. 2018-06-04
Thermo Fisher Scientific Inc.. (6/4/18). "Press Release: Advanced Autosampler and Liquid Handling System Improves Lab Productivity". San Diego, CA. 2018-06-04
Thermo Fisher Scientific Inc.. (6/4/18). "Press Release: New Consumables Improve Analytical Instrument Performance". San Diego, CA. 2018-06-04
Waters Corporation. (6/1/18). "Press Release: Waters Technologies for Food Safety, Food Authenticity and Biomedical Research at ASMS 2018". Milford, MA. 2018-06-01
Sygnature Discovery Ltd.. (6/1/18). "Press Release: Sygnature Discovery Focuses on US Expansion with the Appointment of Dr Bill Marathias". Nottingham. 2018-06-01
Evotec AG. (5/31/18). "Press Release: Evotec Forms Academic Bridge »LAB591« with Arix Bioscience and Fred Hutchinson Cancer Research Center". Hamburg. 2018-05-31
REPO-TRIAl Project. (5/31/18). "Press Release: REPO-TRIAL – a European Union Project for In Silico Trial-Based Drug Repurposing". Maastricht. 2018-05-31
ERS Genomics Ltd.. (5/31/18). "Press Release: ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to NMI and NMI TT Pharmaservices". Dublin & Reutlingen. 2018-05-31
F-Star Biotechnology Ltd.. (5/30/18). "Press Release: F-Star Announces Early Exercise by Denali Therapeutics of Its Option to Acquire F-star Gamma". Cambridge. 2018-05-30
Waters Corporation. (5/29/18). "Press Release: Waters DART QDa System with LiveID Software Instantly Assesses Food Quality and Authenticity". Milford, MA. 2018-05-29
Bicycle Therapeutics Ltd.. (5/25/18). "Press Release: Bicycle Therapeutics Announces Clinical Milestone and Expands Collaboration with Thrombogenics". Cambridge & Boston, MA. 2018-05-25
Markes International Ltd.. (5/25/18). "Press Release: Important Notice – Markes International GmbH Office". 2018-05-25
Bicycle Therapeutics Ltd.. (5/24/18). "Press Release: Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca". Cambridge & Boston, MA. 2018-05-24
Microsaic Systems plc. (5/24/18). "Press Release: Distribution Agreement with Stable Arm Sdn. Bhd.". 2018-05-24
Orbit Discovery Ltd.. (5/23/18). "Press Release: Peptide Display Company Orbit Discovery Closes £6.9M Series A Financing". Oxford. 2018-05-23
HalioDx S.A.S.. (5/22/18). "Press Release: HalioDx Signs an Agreement with Everything Genetic to Make Immunoscore Colon Assay Available in the United Kingdom". Marseille. 2018-05-22
Roche. (5/21/18). "Press Release: Roche’s Hemlibra Reduced Treated Bleeds by 96 Percent Compared to No Prophylaxis in Phase III HAVEN 3 Study in Haemophilia A without Factor VIII Inhibitors". Basel. 2018-05-21
Nabriva Therapeutics plc. (5/21/18). "Press Release: Nabriva Therapeutics Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial of Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia". Dublin & King of Prussia, PA. 2018-05-21
F-Star Biotechnology Ltd.. (5/21/18). "Press Release: F-Star Announces First Patient Dosed in Phase I Clinical Trial of FS118, a First-in-class Immuno-oncology Bispecific Antibody". Cambridge. 2018-05-21
Innate Pharma S.A.. (5/16/18). "Press Release: First Quarter 2018 Report". Marseille. 2018-05-16
Idorsia Ltd.. (5/16/18). "Press Release: Idorsia Initiates MODIFY, a Phase 3 Registration Study to Assess Lucerastat as a Potential New Treatment Option for Patients with Fabry Disease". Allschwil. 2018-05-16
Bionure. (5/16/18). "Press Release: Bionure Initiates a Phase 1 Clinical Trial of Its Lead Compound BN201 in the United Kingdom". Barcelona. 2018-05-16
Thermo Fisher Scientific Inc.. (5/16/18). "Press Release: Thermo Fisher Scientific Installs First Glacios Cryo-Electron Microscope for Drug Discovery and Development". Hillsboro, OR. 2018-05-16
Applied Photophysics Ltd.. (5/15/18). "Press Release: Applied Photophysics Signs Agreements with Alfatest and Paralab to Expand Distribution in Europe". Surrey, Rome & Valborn. 2018-05-15
CellCentric Ltd.. (5/15/18). "Press Release: CellCentric Raises $26 Million to Take First-in-Class p300/CBP Inhibitor into the Clinic". 2018-05-15
IP Group plc. (5/15/18). "Press Release: IP Group and Johns Hopkins Collaboration Funds Cancer Therapeutic Start-up". 2018-05-15
Xenikos B.V.. (5/15/18). "Press Release: Dutch Company Xenikos Secures USD 30 Million in Series B Financing". Nijmegen. 2018-05-15
PhoreMost Ltd.. (5/15/18). "Press Release: PhoreMost Completes $15M (£11M) Series A Round to Enter Drug Discovery". Cambridge. 2018-05-15
Premaitha Health plc. (5/15/18). "Press Release: Year-end Trading Update and £2.5m Fundraising". Manchester. 2018-05-15
Genedrive plc. (5/14/18). "Press Release: Proposed Disposal of the Company's Contract Research and Pharmacogenomics Divisions for up to £1.9 Million in Cash". 2018-05-14
Oryzon Genomics S.A.. (5/14/18). "Press Release: Oryzon Announces First Patients In ETHERAL – a Phase IIa Clinical Trial in Alzheimer’s Disease with ORY-2001". Madrid & Cambridge, MA. 2018-05-14
AstraZeneca plc. (5/11/18). "Press Release: AstraZeneca Provides Update on GALATHEA Phase III Trial for Fasenra in Chronic Obstructive Pulmonary Disease". 2018-05-11
Brainomix Ltd.. (5/11/18). "Press Release: Brainomix Announces CE Mark Certification for New e-CTA Software". Oxford. 2018-05-11
Pieris Pharmaceuticals, Inc.. (5/10/18). "Press Release: Pieris Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update". Boston, MA. 2018-05-10
Memo Therapeutics AG. (5/9/18). "Press Release: Memo Therapeutics AG Closes Series A2 Financing Round of CHF 5 Million to Advance Its Antibody Discovery Programs into Preclinical and Clinical Development". Basel. 2018-05-09
Microsaic Systems plc. (5/9/18). "Press Release: Microsaic Signs Agreement with Rightek Co., Ltd.". 2018-05-09
Oxford Nanopore Technologies Ltd.. (5/9/18). "Press Release: Oxford Nanopore Announces Favourable Outcome in UK and German Patent Litigation against Pacific Biosciences". 2018-05-09
Scancell Holdings plc. (5/8/18). "Press Release: Result of Open Offer and PDMR Shareholdings". 2018-05-08
Autolus Therapeutics Ltd.. (5/8/18). "Press Release: Autolus Files for Proposed Initial Public Offering in the United States". London. 2018-05-08
Horizon Discovery Group plc. (5/8/18). "Press Release: Horizon Discovery Appoints Terry Pizzie as Chief Executive Officer". Cambridge. 2018-05-08
TC BioPharm Ltd.. (5/8/18). "Press Release: TC BioPharm Broadens CAR-T Drug Pipeline". Glasgow & Aberdeen. 2018-05-08
AstraZeneca plc. (5/8/18). "Press Release: Lynparza Tablets Receive EU Approval for the Treatment of Platinum-sensitive Relapsed Ovarian Cancer". 2018-05-08
AstraZeneca plc. (5/7/18). "Press Release: AstraZeneca and Luye Pharma Group Enter Agreement for Rights to Seroquel and Seroquel XR in the UK, China and Other International Markets". 2018-05-07
Caribou Biosciences, Inc.. (5/3/18). "Press Release: Caribou Biosciences Appoints Timothy F. Herpin, Ph.D. as Chief Business Officer". Berkeley, CA. 2018-05-03
Orchard Therapeutics Ltd.. (5/3/18). "Press Release: Orchard Therapeutics’ OTL-200 Receives Rare Pediatric Disease Designation from FDA for Treatment of Metachromatic Leukodystrophy". Boston, MA & London. 2018-05-03
Evotec AG. (5/2/18). "Press Release: Evotec Expands CRISPR-based Technology Offering with Licence from ERS Genomics". Hamburg. 2018-05-02
Mercia Technologies plc. (5/2/18). "Press Release: Mercia’s First University of Edinburgh Investment Offers Dialysis Hope". 2018-05-02
ERS Genomics Ltd.. (5/2/18). "Press Release: ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to Evotec". Dublin. 2018-05-02
Oxford Immunotec Global plc. (5/1/18). "Press Release: Oxford Immunotec Reports First Quarter 2018 Financial Results". Oxford & Marlborough, MA. 2018-05-01
Eagle Genomics Ltd.. (5/1/18). "Press Release: Eagle Genomics Announces Senior Leadership Changes". Cambridge. 2018-05-01
Mologic Ltd.. (5/1/18). "Press Release: Mologic Signs Agreements with Medisur and Peripal to Distribute Periplex PoC Diagnostic in Europe". Bedfordshire. 2018-05-01
PredictImmune Ltd.. (4/30/18). "Press Release: PredictImmune Secures £4.3m Investment from Wellcome Trust to Evaluate The Clinical Utility of Its Prognostic Test in Crohn’s Disease". Cambridge. 2018-04-30
Crescendo Biologics Ltd.. (4/30/18). "Press Release: Crescendo Biologics Ltd. Raises $70 Million (€57 Million) in Series B Financing". Cambridge. 2018-04-30
Eurofins Scientific. (4/30/18). "Press Release: Eurofins to Expand Its Presence in North America, the United Kingdom and Asia with the Acquisition of LabCorp’s Food Testing and Consulting Business". 2018-04-30
Synthorx Inc.. (4/30/18). "Press Release: Synthorx Announces $63 Million Series C Financing to Advance a Pipeline of Synthorin Cytokines". San Diego, CA. 2018-04-30
A-Mansia Biotech S.A.. (4/27/18). "Press Release: Belgian Microbiome Spin-off A-Mansia Announces €13m First Close of Series A Financing". Louvain-la-Neuve. 2018-04-27
Jellagen Pty. Ltd.. (4/27/18). "Press Release: Marine Biotechnologies Firm Jellagen on Course for Accelerated Growth Thanks to £3.8m Funding from Newable Private Investing, Development Bank of Wales and Angel Investors". Cardiff. 2018-04-27
Novacyt S.A.. (4/26/18). "Press Release: Novacyt Full Year 2017 Results". Paris & Camberley. 2018-04-26
Abcam plc. (4/26/18). "Press Release: Abcam and Shuwen Biotech Sign Strategic MoU to Establish Global Alliance for Companion Diagnostic (CDx) Kit Development". Cambridge & Deqing. 2018-04-26
AstraZeneca plc. (4/24/18). "Press Release: AstraZeneca Reports Results from the ARCTIC Trial in Third-line Non-small Cell Lung Cancer". 2018-04-24
PureTech Health plc. (4/24/18). "Press Release: PureTech Health Appoints Joep Muijrers as Chief Financial Officer". 2018-04-24
Redx Pharma plc. (4/24/18). "Press Release: Redx Appoints Senior AstraZeneca Executive as CEO". Alderley Park. 2018-04-24
Orchard Therapeutics Ltd.. (4/24/18). "Press Release: Orchard Therapeutics Expands US Presence with New Corporate Office in Boston". Boston, MA & London. 2018-04-24
Mologen AG. (4/20/18). "Press Release: Chief Executive Officer of Mologen AG Will Not Extend Executive Board Mandate Expiring in October 2018 (Ad-hoc News)". Berlin. 2018-04-20
BenevolentAI. (4/19/18). "Press Release: BenevolentAI Raises $115 Million to Extend Its Leading Global Position in the Field of AI Enabled Drug Development". 2018-04-19
GlaxoSmithKline plc. (4/18/18). "Press Release: GSK Appoints Kevin Sin as New SVP and Head of Worldwide Business Development for R&D". London. 2018-04-18
Adocia S.A.. (4/16/18). "Press Release: Adocia Initiates First-in-Human Clinical Study of BioChaperone Pramlintide Insulin in People with Type 1 Diabetes". Lyon. 2018-04-16
Crescendo Biologics Ltd.. (4/16/18). "Press Release: Crescendo Biologics Reaches First Major Milestone in Strategic Collaboration with Takeda". Cambridge. 2018-04-16
Inflection Biosciences Ltd.. (4/16/18). "Press Release: Inflection Biosciences and Trinity College Dublin Announce Immuno-Oncology Research Collaboration". Dublin. 2018-04-16
Boehringer Ingelheim. (4/16/18). "Press Release: Boehringer Ingelheim and Lilly Announce an Academic Collaboration with University of Oxford to Investigate the Effects of Empagliflozin in People with Chronic Kidney Disease". Ingelheim & Indianapolis, IN. 2018-04-16
Adaptimmune Therapeutics plc. (4/16/18). "Press Release: Adaptimmune Presents MAGE-A4 and MAGE-A10 Pre-clinical Data at American Association for Cancer Research (AACR) Annual Meeting". Philadeliphia, PA & Oxford. 2018-04-16
Adaptimmune Therapeutics plc. (4/12/18). "Press Release: Adaptimmune Announces Changes to Board of Directors". Philadeliphia, PA & Oxford. 2018-04-12
Microsaic Systems plc. (4/12/18). "Press Release: Microsaic Signs Agreement with Knauer". 2018-04-12
GlaxoSmithKline plc. (4/12/18). "Press Release: GSK Signs Strategic Agreement to Transfer Rare Disease Gene Therapy Portfolio to Orchard Therapeutics". London. 2018-04-12
Enterprise Therapeutics Ltd.. (4/12/18). "Press Release: Enterprise Therapeutics Raises £29 Million ($41 Million USD) Funding". Brighton. 2018-04-12
Humedics GmbH. (4/12/18). "Press Release: The LiMAx Liver Capacity Test Is Now Commercially Available in Germany, Austria and the UK". Berlin & Paris. 2018-04-12
BioAscent Discovery Ltd.. (4/12/18). "Press Release: BioAscent Establishes Integrated Drug Discovery Services Offering". Newhouse. 2018-04-12
Microsaic Systems plc. (4/10/18). "Press Release: Microsaic Systems Launches 4500 MiD for Point-of-need Mass Spectrometry at Analytica 2018". 2018-04-10
Argen-X N.V. (Argenx). (4/9/18). "Press Release: Argenx Appoints Keith Woods as Chief Operating Officer". Breda & Ghent. 2018-04-09
Markes International Ltd.. (4/9/18). "Press Release: New Sample Preparation and Concentration Platform Marks a Major Advance in Automation of GC–MS Workflows". Llantrisant. 2018-04-09
Consilium Strategic Communications Ltd.. (4/9/18). "Press Release: Consilium Strategic Communications Appoints GSK’s David Daley as Senior Associate Partner". London. 2018-04-09
Iontas Ltd.. (4/4/18). "Press Release: Iontas and Igem Therapeutics Collaborate to Identify Novel IgE Antibodies for Cancer Targets". Cambridge. 2018-04-04
Brainomix Ltd.. (4/3/18). "Press Release: Brainomix Secures £7m ($9.8m) Investment to Tackle Strokes with AI". Oxford. 2018-04-03
Compugen Ltd.. (4/2/18). "Press Release: Compugen Announces Exclusive License Agreement with MedImmune for the Development of Bi-specific and Multi-specific Antibody Products". Holon. 2018-04-02
Peak Scientific Instruments Ltd.. (4/2/18). "Press Release: Peak Scientific Introduces New Solaris XE Nitrogen Generator". 2018-04-02
Macrolide Pharmaceuticals, Inc.. (4/2/18). "Press Release: Macrolide Pharmaceuticals Appoints New President and CEO. Raises $20 Million in Investor Financing". 2018-04-02
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29  next pagenext page



Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group Bio-Europe Spring 2019 Vienna Austria March 600x60px

» top